AB
Applied BioSciences Corp. Stock: price and insider trades · United States
Applied BioSciences Corp.: what insiders have been doing
Insider filings for Applied BioSciences Corp. are scarce in the SEC (Form 4) feed, the latest one published on 16 September 2019. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€21,657
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
US$0.00
Analyst consensus
Income statement
EBITDA-US$2.5M
Valuation
P/Book0.0x
Beta80.03
Balance sheet & cash
Debt / Equity101%
Profitability & ownership
ROE-221.6%
ROA-64.1%
% insiders32.2%
% institutions0.0%
Last declaration on 16 September 2019
Declarations8 total
- 100,000 shares0Common StockSEC:0001477932-19-005406:0
- 25,000 shares@ US$1.00100.0% of flowcommon stockSEC:0001477932-19-000429:0
- 200,000 shares0Common StockSEC:0001477932-19-000425:0
- 100,000 shares0Common StockSEC:0001477932-19-000425:1
- 200,000 shares0common stockSEC:0001477932-19-000429:1
- 225,000 shares0Common StockSEC:0001477932-19-000427:0
- 139,000 shares0Common StockSEC:0001477932-18-004291:0
- 150,000 shares0Common StockSEC:0001477932-18-001199:0
8 of 8 declarations
About Applied BioSciences Corp.
Applied BioSciences Corp. is a company focused on developing biopharmaceutical solutions. It emphasizes innovation in the life sciences sector.
